Quick Order Cart

Cat. No. ARG32612

HPS3 Knockout SK-HEP-1 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Liver

  • Disease:

    Adenocarcinoma

The HPS3 Knockout SK-HEP-1 Polyclonal Cells offer a CRISPR/Cas9-edited polyclonal knockout population of HPS3 in the SK-HEP-1 human liver adenocarcinoma cell line, a model of liver sinusoidal endothelial cells. HPS3 is a BLOC-2 complex subunit critical for trafficking to lysosome-related organelles, interacting with HPS5, HPS6, and downstream effectors like TYR and TYRP1. This polyclonal knockout model is ideal for studying Hermansky-Pudlak syndrome type 3, melanosome and platelet dense granule biogenesis, and vesicular trafficking. Typical applications include immunofluorescence, Western blotting, co-immunoprecipitation, and functional organelle assays.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    SK-HEP-1

    Sex of Donor

    Male

    Age

    52 years

    Gene Name

    HPS3

    Gene Identifier

    NCBI Gene ID 84343

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    MEM (with NEAA)

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The HPS3 Knockout SK-HEP-1 Polyclonal Cells product comprises a CRISPR/Cas9-edited polyclonal knockout cell population derived from the SK-HEP-1 human liver adenocarcinoma cell line, engineered for targeted disruption of the HPS3 gene. This polyclonal knockout pool offers a loss-of-function model for investigating HPS3-dependent pathways without the need for single-cell cloning, providing a heterogeneous mixture of edited alleles representative of a population-level knockout effect.

The parental SK-HEP-1 cell line originates from the ascitic fluid of a patient with liver adenocarcinoma and is extensively employed as an in vitro model for liver sinusoidal endothelial cells, despite its epithelial origin. This cell line retains characteristics relevant to hepatic endothelial biology, including the expression of certain endothelial markers, making it suitable for studies of liver-specific vesicular trafficking and organelle dynamics.

HPS3 encodes a subunit of the biogenesis of lysosome-related organelles complex-2 (BLOC-2), forming a functional module with HPS5 and HPS6 that mediates cargo transport from early endosomes to lysosome-related organelles, including melanosomes and platelet dense granules. The complex acts downstream of AP-3 and cooperates with Rab32 and Rab38 to deliver melanosomal proteins such as TYR and TYRP1, lysosomal enzymes, and dense granule components. HPS3 knockout abrogates this trafficking, disrupting organelle maturation.

In the SK-HEP-1 hepatic endothelial-like context, HPS3 knockout allows dissection of BLOC-2-dependent trafficking specific to this cell type. It also permits examination of how defective organelle biogenesis intersects with hepatocellular carcinoma biology, given the cell line??s dual epithelial?Cendothelial phenotype. The model is pertinent to studying platelet dense granule and melanosome defects underlying the bleeding diatheses and albinism of Hermansky-Pudlak syndrome type 3.

Typical applications include immunofluorescence for organelle markers, Western blotting of BLOC-2 components, electron microscopy, platelet dense granule ATP release assays, and melanosome maturation assays. Co-immunoprecipitation can assess complex integrity, and RT-qPCR verifies gene disruption. Thus, these cells are valuable for Hermansky-Pudlak syndrome research, organelle biogenesis studies, pigmentation disorder investigations, and platelet granule formation analyses. For further information or to discuss customized knockout solutions, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)